Redhill Biopharma Ltd. (RDHL) is a publicly traded Healthcare sector company. As of November 17, 2026, RDHL trades at $0.38 with a market cap of $3.33M and a P/E ratio of 0.00. RDHL moved +5.41% today. Year to date, RDHL is -64.47%; over the trailing twelve months it is -65.79%. Its 52-week range spans $0.36 to $3.31. Rallies surfaces RDHL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RDHL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDHL recently traded at $0.38. Market cap is $3.33M. P/E ratio is 0.00. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.38 |
| Market Cap | $3.33M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $3.31 |
|---|
| 52-Week Low | $0.36 |
|---|
| Volume | 4.29K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $0 |
|---|
| Gross Margin | 0.00% |
|---|
RDHL analyst coverage data. Average price target: $0.00.